Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,436.85
(
-0.86%
)
US TECH 100
28,444.80
(
-1.20%
)
Dow Jones
49,738.90
(
-0.65%
)
Brent Oil
106.31
(
2.04%
)
Bitcoin
79,070.32
(
-2.45%
)
News Focus
News Focus
Post# of 257568
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122984
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 62161

Wednesday, 04/30/2008 11:56:13 PM

Wednesday, April 30, 2008 11:56:13 PM

Post# of 257568
MNTA – The following is obvious, but perhaps it ought to stated anyhow in light of drbio’s post:

If MNTA/Sandoz’s Lovenox is approved and Teva’s and Amphastar’s are not, MNTA/Sandoz’s Lovenox will be the largest-selling generic drug in history by a wide margin.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today